Results 111 to 120 of about 7,354,999 (259)
Egyptian Journal of Chest Disease and TuberculosisIntroduction Variations in the response to allergen immunotherapy are significant among patients. Since allergen-specific immunotherapy (AIT) is long-lasting, having a marker that can predict allergen immunotherapy responders is highly important. In this
Heba W. Abdelwahab +3 more
doaj +1 more source
Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper
Allergy, EarlyView.ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres +19 more
wiley +1 more source
Expert consensus on hypodermic care for allergen-specific immunotherapy
Allergy MedicineObjective: To develop an expert consensus on subcutaneous injection for allergen-specific immunotherapy. Methods: Relevant domestic and international literature was reviewed, and nursing experts experienced in subcutaneous injection of allergen-specific ...
Wang Qing +9 more
doaj +1 more source
, 2018 DIZDAR, DENIZHAN/0000-0002-0991-2706; DIZDAR, DENIZHAN/0000-0002-0991-2706Background: Allergic rhinitis is strongly associated with the presence of house dust mites.
Şahin, Ethem +3 more
core +1 more source
Allergy, EarlyView.ABSTRACT Allergen immunotherapy (AIT) has been acknowledged as the only disease‐modifying treatment for respiratory diseases since its introduction in 1911. Although the efficacy and safety have convincingly been established in numerous randomized clinical trials (RCTs), the AIT study results may vary substantially.
Roy Gerth van Wijk +10 more
wiley +1 more source
Allergen specific immunotherapy attenuates allergic rhinitis clinical manifestations
Медицинская иммунологияThe prevalence of allergic diseases, including rhinitis and allergic asthma, is increasing in the modern world based on the Hygiene theory. Avoidance of allergens and using drugs to relieve clinical symptoms in these patients are not sufficient and ...
S. A. Hashemi Moghaddam +4 more
doaj +1 more source
Allergen-specific immunotherapy from the perspective of nurses.
, 2014 The subject matter of the bachelor thesis is specific allergen immunotherapy from the perspective of nurses. The work is divided into theoretical and practical parts.
BEJTICOVÁ, Lenka
core
Failed Mucosal Allostasis Distinguishes Murine IgG‐ From IgE‐Mediated Recurrent Severe Anaphylaxis
Allergy, EarlyView.This study investigates IgE‐ and IgG‐mediated pathways in acute and recurrent anaphylaxis using a murine ASA‐PSA model, assessing barrier integrity, immune activation and tissue remodelling across pulmonary and intestinal compartments. Recurrent IgE‐ and IgG‐mediated anaphylaxis produces divergent mucosal outcomes despite comparable systemic severity ...
Abdurrahman Simsek +8 more
wiley +1 more source
Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials
, 2010 PURPOSE OF REVIEW: IgE-mediated allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, today affecting up to 35% of the population in industrialized countries.
Kundig, T M +5 more
core +1 more source
Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy
Allergy, EarlyView.We conducted a two stage SCIT trial with GNR‐127 containing a recombinant fusion protein consisting of Bet v 1 and Mal d 1‐derived peptides fused to PreS from HBV. Stage 1 identified two safe maximum tolerated doses (40 μg and 80 μg). In the following Stage 2, five preseasonal injections were well tolerated, induced dose‐dependent allergen‐specific IgG,
Musa R. Khaitov +43 more
wiley +1 more source